🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honestly considered flying up so I could also boo his dumb ass.

“Together, let’s ensure their love and dedication continue to flourish, reshaping the world into a safer space for all.” Fengting Yan. MD, PhD, FACP. of Providence Swedish seattletimes.com/opinion/our-fa…

A thread about our depraved healthcare system, and a plea. In 2021, my friend Carole was diagnosed with terminal stage four cancer. A single parent with two kids, she had just turned 43. In 2017, she had watched her brother Chris die of the same cancer. He too was in his 40s.

Bravo to the Tropion-01 study for putting QOL measures as key 2nd endpoints. This should be a new standard for our important studies! #sabcs2023

If you have more podium presentations than grandkids you probably should allow a younger faculty to have the opportunity to get this honor. Same people year after year presenting at #sabcs2023

We are proud to work with so many incredible institutions and investigators on breast cancer research #SABCS2023 Our 3rd abstract at the symposium is PO5-20-04 SABCS Alison conlin VK Gadi University of Illinois Cancer Center Perlmutter Cancer Center at NYU Langone Health UW Health | Carbone Cancer Center

🗣️ SABCS made changes promoting career development↗️ 🐶wellness initiatives 👧childcare 🤝mentorship ‼️One more All urged to present only1️⃣scientific session so— 🎙️more voices at podium 🌎more people present on global stage 👏🏻 #SABCS23, authors creating opportunities

Merry Christmas, #RipCity

🫶 This is a Jabari Walker appreciation post 🫶

A clinical trial is a research study that assesses the safety and effectiveness of a cancer treatment. This JAMA Oncology Patient Page explains clinical trials and what patients should consider regarding enrollment. ja.ma/3SfJXyk

Little activity (<10% ORR) with sunitinib in patients with MBC harboring FGFR1 or FGFR2 alterations (n=40). Remains an elusive target in breast oncology. Congrats to the TAPUR investigators. ascopubs.org/doi/10.1200/PO…

Check out our newest consensus-based treatment guideline on the use of bone-modifying agents in patients with #BreastCancer. #BOCGuideline #CancerGuideline #bcsm physicianresources.dana-farber.org/symposium/brea…

Congrats to PCI Willamette Falls oncology nurse practitioner Jamie Zilverberg, MSN, FNP, AOCNP, for receiving the 2024 Providence Values in Action Award! Jamie was one of just ten caregivers selected for this prestigious award! Read more: blog.providence.org/cancer/provide…. #ValuesinAction

#ASCO24 ProTip— Be this moderator ⬇️⬇️⬇️ Also—introduce all speakers correctly & formally. Ask for title & pronunciation. Practice. YOU CAN DO IT! See: ascopubs.org/doi/abs/10.120… 🙌🏻

This show. It’s always this show.

“One coffee after 2pm shouldn’t hurt” *2am

Many people don’t want to believe it — because it means it could happen to them — but so much cancer is just bad luck

The Indiana Fever had higher attendance than the Indiana Pacers in 2024 😳 Average fan attendance: 🤯 Fever: 17,035 🧱 Pacers: 16,528 (Via Across the Timeline)

I voted!!! Oregon has all mail in ballots! Also I voted again, but this time for ASCO elections!

Do pts with small (≤1cm) ER+ tumors with high genomic risk benefit from chemo? Interesting analysis of MINDACT: favorable outcomes (93% 8y DMFS) & no clear benefit from chemo despite high genomic risk. Think twice before giving chemo for T1a/b ER+ tumors. nature.com/articles/s4152…